Dr Michael A Fontes, MD in Dallas, TX - Medicare Anesthesiology

Dr Michael A Fontes, MD is a medicare enrolled "Anesthesiology" physician in Dallas, Texas. He went to Creighton University School Of Medicine and graduated in 1991 and has 33 years of diverse experience with area of expertise as Anesthesiology. He is a member of the group practice U S Anesthesia Partners Of Texas, Pa and his current practice location is 6606 Lbj Fwy Ste 200, Dallas, Texas. You can reach out to his office (for appointments etc.) via phone at (972) 715-5000.

Dr Michael A Fontes is licensed to practice in Texas (license number K8156) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1124022116.

Contact Information

	Dr Michael A Fontes, MD
	6606 Lbj Fwy Ste 200, Dallas, TX 75240
	(972) 715-5000
	Not Available

Physician's Profile

Full Name	Dr Michael A Fontes
Gender	Male
Speciality	Anesthesiology
Experience	33 Years
Location	6606 Lbj Fwy Ste 200, Dallas, Texas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Michael A Fontes attended and graduated from Creighton University School Of Medicine in 1991

NPI Data:

NPI Number: 1124022116
Provider Enumeration Date: 06/08/2005
Last Update Date: 06/17/2020

Medicare PECOS Information:

PECOS PAC ID: 2668476821
Enrollment ID: I20060831000365

Medical Identifiers

Medical identifiers for Dr Michael A Fontes such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1124022116	NPI	-	NPPES
106185506	Medicaid	TX
P00691715	Other	TX	RAILROAD
106185507	Other	TX	MEDICAID CSHCN
106185505	Medicaid	TX
8BR513	Other	TX	BCBS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	K8156 (Texas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Baylor University Medical Center	Dallas, TX	Hospital
Baylor Scott And White Medical Center Uptown	Dallas, TX	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
U S Anesthesia Partners Of Texas, Pa	7315850351	2379

News Archive

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Vanda Pharmaceuticals Inc. today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD). The trial is expected to begin during the second half of 2011. Tasimelteon is currently being evaluated in Phase III clinical trials for the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals without light perception.

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Scalp cooling is a safe, feasible and an effective treatment in the prevention of chemotherapy induced alopecia (CIA) according to a German study being presented at the American Society of Clinical Oncology Annual meeting (ASCO).

Experts predict 125,000 fewer COVID deaths if 50% of U.S. population initiate vaccination by March 1

A new report combining forecasting and expert prediction data, predicts that 125,000 lives could be saved by the end of 2021 if 50% or more of the U.S. population initiated COVID vaccination by March 1, 2021.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Michael A Fontes allows following entities to bill medicare on his behalf.

Entity Name	U S Anesthesia Partners Of Texas, Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563

News Archive

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Experts predict 125,000 fewer COVID deaths if 50% of U.S. population initiate vaccination by March 1

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Michael A Fontes is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Michael A Fontes, MD Po Box 840853, Dallas, TX 75284-0853 Ph: (972) 715-5000	Dr Michael A Fontes, MD 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Ph: (972) 715-5000

News Archive

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Experts predict 125,000 fewer COVID deaths if 50% of U.S. population initiate vaccination by March 1

Anesthesiology Doctors in Dallas, TX

Lee M. Lunsford, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-8000
Dr. Stephanie C Jones, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9374
Dr. Alfredo Ruben Lopez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000 Fax: 972-715-9976
Dr. Elvis Tsang, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12222 Merit Dr Ste 600, Dallas, TX 75251 Phone: 972-715-5000 Fax: 972-715-9976
Dr. Christopher D Lecheminant, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000
Dr. Mihir N Rane, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3625 N Hall St Ste 800, Dallas, TX 75219 Phone: 214-252-3500
Lisa Gu, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-6400

Dr Michael A Fontes, MD - Medicare Anesthesiology in Dallas, TX

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Experts predict 125,000 fewer COVID deaths if 50% of U.S. population initiate vaccination by March 1

Medicare Reassignments

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Experts predict 125,000 fewer COVID deaths if 50% of U.S. population initiate vaccination by March 1

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Experts predict 125,000 fewer COVID deaths if 50% of U.S. population initiate vaccination by March 1

Anesthesiology Doctors in Dallas, TX